Compare ARK Genomic Revolution ETF (ARKG) vs Manchester United PLC (MANU) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Manchester United PLC — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Manchester United PLC trades at $22.28 (market cap $3.80B). The key difference: Manchester United PLC pays a 1.26% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | MANU | |
|---|---|---|
Sector | Sector/Thematic | Media |
52-Week High | $43.57 | $23.53 |
52-Week Low | $23.09 | $15.10 |
Market Cap | — | $3.80B |
Enterprise Value | — | $4.72B |
Dividend Yield | — | 1.26% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Manchester United (MANU) trades at $22.04, up 0.18% today, with a bullish technical signal and positive news flow around stadium development. The company reported mixed quarterly earnings but achieved Champions League qualification, boosting future revenue prospects. However, fundamentals show persistent net losses and negative ROE, with a high P/B ratio of 16.05 indicating premium valuation despite profitability challenges.
The outlook is cautiously optimistic, driven by stadium expansion plans and improved sporting performance, but significant execution risks and ongoing financial losses warrant careful monitoring. Analyst sentiment is mixed with 40% buy ratings, reflecting the balance between growth potential and current weak profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Manchester United PLC
Manchester United PLC operates a professional football club together with related and ancillary activities. The company manages the soccer team and all affiliated club activities of the Manchester United Football Club, which includes the media network, foundation, fan zone, news, sports features, and team merchandise. Manchester United is based in England. The company has three principal sectors from which most of the revenue is generated, including Commercial, Broadcasting, and Matchday.
Read more on MANU →
